MedPath
HSA Approval

RIMONAL EYE DROPS 0.15% w/v

SIN17034P

RIMONAL EYE DROPS 0.15% w/v

RIMONAL EYE DROPS 0.15% w/v

June 28, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01EA05

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

World Medicine İlaç San ve Tic. A.Ş.

Active Ingredients

Brimonidine Tartrate

0.15 % w/v

Brimonidine

Documents

Package Inserts

Rimonal Eye Drops 0.15% PI.pdf

Approved: June 28, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RIMONAL EYE DROPS 0.15% w/v - HSA Approval | MedPath